Meeder Asset Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Meeder Asset Management’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3,526	Closed	-$9K	–	2534
2020 Q1	$9K	Buy	3,526 +2,326	+194%	+$5.71K	﹤0.01%	1585
2019 Q4	$3K	Buy	1,200 +587	+96%	+$1.75K	﹤0.01%	1955
2019 Q3	$2K	Sell	613 -1,147	-65%	-$4.06K	﹤0.01%	2002
2019 Q2	$6K	Buy	+1,760	New	+$6.2K	﹤0.01%	1626
2019 Q1	–	Sell	-406	Closed	-$1K	–	1898
2018 Q4	$1K	Sell	406 -18	-4%	-$59	﹤0.01%	1664
2018 Q3	$2K	Buy	+424	New	+$1.93K	﹤0.01%	1448
2018 Q1	–	Sell	-5,549	Closed	-$45K	–	1779
2017 Q4	$45K	Buy	5,549 +5,306	+2,184%	+$50.7K	﹤0.01%	719
2017 Q3	$3K	Sell	243 -78	-24%	-$866	﹤0.01%	1391
2017 Q2	$4K	Buy	+321	New	+$2.99K	﹤0.01%	1281

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

Meeder Asset Management's ENZ Position: Q2 2020 in Review

Meeder Asset Management sold out of Enzo Biochem, Inc. (ENZ) in Q2 2020, closing a stake of 3,526 shares — an estimated $9K sold.

Meeder Asset Management first reported a position in ENZ in Q2 2017 and held it in 9 quarters. The position peaked at $45K in Q4 2017. 84 funds tracked by Wall St. Rank hold ENZ as of Q2 2020.

Meeder Asset Management reported no remaining Enzo Biochem, Inc. position as of Q2 2020 after selling out during the quarter.
Meeder Asset Management sold 3,526 Enzo Biochem, Inc. shares in Q2 2020, an estimated $9K.
Meeder Asset Management first reported a position in Enzo Biochem, Inc. in Q2 2017 and held it in 9 quarters.
Meeder Asset Management's Enzo Biochem, Inc. position peaked at $45K in Q4 2017.
84 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2020.

Based on Meeder Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.